|
|
| Line 25: |
Line 25: |
|
| |
|
| ==Pathology== | | ==Pathology== |
| Already in 2001 Lin et al showed that ''SYNPO2'' gene exhibit frequently delations in aggresive prostata cancer <ref> PMID:11696420</ref>. Later analysis gave the evidence that Myopodin plays an important role as tumor suppressor, considering that in normal urothelium of the bladder Myopodin is localized in the cytoplasm and in the nucleus, however in mutated tissue of superficial and invasive bladder tumor is observed a reduced nuclear expression of Myopodin <ref> PMID:12917631 </ref>. Furthermore the expression of Myopodin suppressed tumor growth and metastasis <ref> PMID:15111326 </ref>. However these observations appear in contradiction with other experiments from Linnemann A. Diplom Thesis 2005 and Krueger Diplom Thesis 2007, where the expression of Myopodin at the protein level could be verify merely in muscle cells.
| | The SYNPO2 gene frequently exhibits deletions in aggresive prostate cancer tissues <ref> PMID:11696420</ref>. Myopodin was suggested to play a role as tumor suppressor, because in normal urothelium of the bladder myopodin is localized both in the cytoplasm and in the nucleus, wheras in superficial and invasive bladder tumors, reduced nuclear expression of myopodin was observed <ref> PMID:12917631 </ref>. The expression of myopodin suppressed tumor growth and metastasis <ref> PMID:15111326 </ref>. |
| | |
|
| |
|
| ==References== | | ==References== |
| <references/> | | <references/> |
